department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Sanofi ($SNYNF) · pharmadog

PUBLIC COMPANY

$SNYNFSanofi

updated 2mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

0

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(0)

no pipeline products on record

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Sanofi jobs →

News

Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
Welcome back to another edition of Endpoints Weekly! We’re doing a little bit of celebrating here at Endpoints, as we took home three Neal Awards, which recognize excellence in B2B journalism. The ...
endpoints · 2mo ago
STAT+: FDA to speed up review of three psychedelics as mental health treatments

Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.

stat · 2mo ago

Sanofi MS drug rejected in US gets an endorsement in Europe

<figure><div><img src="https://imgproxy.divecdn.com/FBR1IQNmU9Hqatva496Zg2G8JMHsqV0UGsf4LMARqYo/g:nowe:189:144/c:1776:1003/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS80OTY5MDc4Mzc…

biopharma_dive · 2mo ago

STAT+: Sanofi MS drug gets positive review in Europe following FDA

A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.

stat · 2mo ago

Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejection

Sanofi’s tolebrutinib is on track to get an approval in Europe for a type of multiple sclerosis even after receiving a complete response letter from the FDA in December. On Friday, the European M…

endpoints · 2mo ago

STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead

A deal with Regeneron was the last of 17 initially sought by the White House.

stat · 2mo ago

STAT+: Sanofi research priorities in flux as new CEO logs in

A gene therapy for deafness, all eyes on Erasca, and other biotech news from The Readout

stat · 2mo ago

Sanofi posts upbeat sales as R&D pressure builds

<figure><div><img src="https://imgproxy.divecdn.com/4sV6C1TzSj2YZ2rz0W5-EST8xmsio5JNKmZoYu-be_8/g:nowe:0:87/c:520:294/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…

biopharma_dive · 2mo ago

Sanofi defends Garijo appointment, says it is 'fully committed' to immunology

Sanofi’s first-quarter earnings call with the media on Thursday was an exercise in redirecting the narrative before its new CEO steps in next week. CFO François-Xavier Roger defended the compan…

endpoints · 2mo ago

Merck adds to pharma’s AI push; Roche details MS drug results

<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…

biopharma_dive · 2mo ago

view all news mentions →

identifiers

ticker

$SNYNF

SEC CIK

0001121404

source

sec_tickers

mentioned in

10news items

entity-linker matched

$SNYNF

Data sources

last refreshed 47m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval433 co-mentions · 217 sources
company$SNYSanofi234 co-mentions · 225 sources
drugRIFADIN233 co-mentions · 117 sources
tagSmall Molecule168 co-mentions · 168 sources
drugrifampin117 co-mentions · 117 sources
drugRIFATER50 co-mentions · 25 sources
drugPRIMAQUINE36 co-mentions · 18 sources
drugPRIFTIN34 co-mentions · 17 sources